Get started
BLUEBIRD BIO, INCBLUEBIRD BIO, INCBLUEBIRD BIO, INC

BLUEBIRD BIO, INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

BLUE chart


Full chart

BLUE upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪937.26 M‬ MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−518.22 MXN
Net income (FY)
‪−5.02 B‬ MXN
Revenue (FY)
‪1.75 B‬ MXN
Shares float
‪9.68 M‬
Beta (1Y)
−0.19

Employees


Employees (FY)
248
Change (1Y)
−127 −33.87%
Revenue / Employee (1Y)
‪7.05 M‬ MXN
Net income / Employee (1Y)
‪−20.24 M‬ MXN

About bluebird bio, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Andrew Obenshain
Website
bluebirdbio.com
Headquarters
Somerville
Founded
1992
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BLUE news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as BLUE.

Frequently Asked Questions


The current price of BLUE is 99.00 MXN — it has increased by 23.75% in the past 24 hours. Watch BLUEBIRD BIO, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange BLUEBIRD BIO, INC stocks are traded under the ticker BLUE.
BLUE stock has risen by 24.87% compared to the previous week, the month change is a 24.87% rise, over the last year BLUEBIRD BIO, INC has showed a 387.20% increase.
We've gathered analysts' opinions on BLUEBIRD BIO, INC future price: according to them, BLUE price has a max estimate of 162.60 MXN and a min estimate of 101.63 MXN. Watch BLUE chart and read a more detailed BLUEBIRD BIO, INC stock forecast: see what analysts think of BLUEBIRD BIO, INC and suggest that you do with its stocks.
BLUE stock is 19.94% volatile and has beta coefficient of −0.19. Track BLUEBIRD BIO, INC stock price on the chart and check out the list of the most volatile stocks — is BLUEBIRD BIO, INC there?
Today BLUEBIRD BIO, INC has the market capitalization of ‪937.26 M‬, it has increased by 29.29% over the last week.
Yes, you can track BLUEBIRD BIO, INC financials in yearly and quarterly reports right on TradingView.
BLUEBIRD BIO, INC is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
BLUE earnings for the last quarter are −118.32 MXN per share, whereas the estimation was −128.20 MXN resulting in a 7.70% surprise. The estimated earnings for the next quarter are −75.53 MXN per share. See more details about BLUEBIRD BIO, INC earnings.
BLUEBIRD BIO, INC revenue for the last quarter amounts to ‪525.95 M‬ MXN, despite the estimated figure of ‪567.20 M‬ MXN. In the next quarter, revenue is expected to reach ‪697.76 M‬ MXN.
BLUE net income for the last quarter is ‪−598.63 M‬ MXN, while the quarter before that showed ‪−1.20 B‬ MXN of net income which accounts for 50.04% change. Track more BLUEBIRD BIO, INC financial stats to get the full picture.
No, BLUE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 248 employees. See our rating of the largest employees — is BLUEBIRD BIO, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BLUEBIRD BIO, INC EBITDA is ‪−4.30 B‬ MXN, and current EBITDA margin is −246.35%. See more stats in BLUEBIRD BIO, INC financial statements.
Like other stocks, BLUE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BLUEBIRD BIO, INC stock right from TradingView charts — choose your broker and connect to your account.